Jun 27, 2024, 13:40
New study on germline CDH1 variants shows lifetime cancer risks
Yüksel Ürün shared on X:
“New study on germline CDH1 variants shows lifetime cancer risks:
- Gastric cancer: 7% to 10% by age 80
- Breast cancer (female carriers): 37%
- These findings indicate a lower gastric cancer risk and similar breast cancer risk compared to previous estimates. Important for current management strategies in CDH1 variant carriers.”
Read further.
Source: Yüksel Ürün/X
Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey. His research focuses on genitourinary cancers, covering epidemiology, diagnosis, biomarkers, meta-analysis, and treatment outcomes. His dedication to patient care and research inspires positive change in the medical field.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 21, 2025, 09:18
Feb 21, 2025, 09:07
Feb 21, 2025, 09:00
Feb 21, 2025, 08:19
Feb 21, 2025, 06:20
Feb 20, 2025, 11:19